A B S T R A C T We studied the effect of thyroid hormone administration on responsivity of murine thyroid to exogenous thyrotropin (TSH) in order to explore the possibility that the thyroid gland might be directly inhibited by its own hormones. In the rat both L-thyroxine (T4) and 3,5,3'-L-triiodothyronine (T3) pretreatment inhibited TSH-induced thyroidal ornithine decarboxylase (ODC) activity in vivo in a dose-related manner (half-maximal inhibition, 1.7 /Ag/rat and 0.6 /Lg/rat, respectively). Other structurally related compounds exhibited the following inhibitory potencies compared to T4: T3, 283%; triiodothyroacetic acid, 40%; D-T4, 18%; 3,5-L-diiodothyronine, 9%. Monoiodotyrosine, diiodotyrosine, and iodide were not inhibitory. The full inhibitory effect of T4 or T3 was observed when thyroid hormone was administered from 96 to 12 h before TSH and was also seen in hypophysectomized animals. Pretreatment with T4 or T3 in divided doses over 2i days inhibited TSH-induced increase in [1-14C]glucose oxidation to 14CO2 and [3H]leucine incorporation into protein in rat thyroid.
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In the mouse T4 or T3 pretreatment (0. Ag daily) caused dose-related inhibition of both thyroidal ODC activity and "31I release induced by TSH in vivo.
In mice on a low-iodine diet (LID) but not in animals on a regular diet (RD) NaI pretreatment also blunted TSH-induced thyroidal ODC activation and "'I release. When LID or RD mice were pretreated with 12.5-125 ,ug of T4 or T3 over 2i days, TSH-induced in vitro stimulation of thyroid cyclic 3',5'-adenosine monophosphate formation was inhibited in a dose-related manner; NaI pretreatment was inhibitory in the LID mouse only.
This work was presented, in part, to the 7th International Thyroid Conference, Boston, Mass., 9 June 1975.
INTRODUCTION
The results of recent studies (1, 2) suggest that an increase in circulating thyroid hormone levels may impair thyroidal responsivity to exogenous thyrotropin (TSH).' It was therefore felt to be of interest to explore this possibility further by studying the effect of thyroid hormone administration on TSH-augmented thyroid function in the rat and mouse. The results indicate that such treatment does, in fact, occasion decreased thyroid gland response to exogenous TSH and suggest the existence of a "short-loop" negative feedback regulating thyroid function.
METHODS
The rat Male Holtzman rats, weighing 180-200 g, were maintained on standard laboratory chow and tap water. Five animals were usually assigned to each treatment group. At the time of sacrifice the rats were anesthetized with ether and killed by a blow on the head. The thyroid gland was removed immediately thereafter, trimmed, and weighed. The average pooled weight of the five glands used in these studies was between 50 and 60 mg.
Hypophysectomized rats were obtained from Hormone Assay Laboratories, Chicago, Ill. These animals were also maintained on standard laboratory chow and tap water ad lib. supplemented only by orange slices. Animals were used for ornithine decarboxylase assay 2-4 days after hypophysectomy. At the end of the experiments, the animals were killed, and the hypophysial fossa was examined with a 10 X dissecting microscope to ascertain the completeness of hypophysectomy. No pituitary remnants (other than the proximal end of the stalk) were found in any animal. Additionally, circulating TSH levels in these animals were measured by radioimmunoassay (3) before experimentation (using reagents supplied by the National Institutes of Arthritis, Metabolism, and Digestive Diseases Rat Pituitary Hormone Distribution Program) and uniformly found to be < 6 A^U/ml ( 3) .
Ornithine decarboxylase (ODC) assay. Animals were killed 4 h after i.p. administration of TSH; timing of thyroid hormone pretreatment was generally 20 or NaI (5 ,ug in 0.2 ml normal saline), or 0.2 ml normal saline twice daily (9:00 a.m. and 4:00 p.m.) for 2 days. On the 3rd day, the hormone, iodide, or saline was administered i.p. 1 h before death. Six rats were assigned to each experimental group; the 12 thyroid lobes so obtained were selectively distributed to three tubes so that no paired lobes were placed in the same tube. Glucose oxidation was measured by the method of Tong (6) In an additional series of cyclic AMP experiments, thyroid glands were removed from untreated RD mice and preincubated under an atmosphere of 95%o 0-5%o C02 with T4, T3, or NaI in Krebs-Ringer bicarbonate buffer (containing glucose and albumin as described above but without theophylline) for 3 h at 370C; thereafter, the glands were removed from the incubation medium, washed twice with buffer, blotted, and incubated with TSH as described above.
All data were analyzed for statistical significance by Student's t test (two-tailed) unless otherwise stated.
Chemicals and Reagents. TSH (Thytropar) was purchased from Armour Pharmaceutical Co., Kankakee, Ill. T4, T3, D-T4, diiodothyronine, diiodotyrosine, monoiodotyrosine, tyrosine, and dithiotreitol were purchased from Sigma Chemical Co., St. Louis, Mo. NCS tissue solubilizer was purchased from Amersham/Searle Corp. Fetal calf serum and Eagle's Basal medium (Earle's salts) were purchased from Grand Island Biological Co., Grand Island, N. Y.
T3, T4, and their analogues were prepared for in vivo or in vitro use by solubilization in the minimum quantity required of 0.025 N NaOH; further dilution was made with normal saline to the final volume of 0.2 ml used for administration to rat or mouse. For the control or NaItreated groups, a similar minimal quantity of 0.025 N NaOH was added to the normal saline or NaI to make the final injection solutions of similar alkalinity to the solutions of iodothyronine hormones and their analogues. The inhibitory effect of thyroid hormone pretreatment on TSH-induced ODC activity is dose related (Fig. 2) ; the half-maximal inhibitory dose of T4 is 1.7 isg/rat, and that of T3 is 0.6 ,ug/rat. Rats pretreated with large doses of NaI show no alteration in TSHinduced thyroid ODC activity.
RESULTS

The
As can be seen from Table I , the maximal increase in circulating T4 and T3 levels associated with pretreatment of the rats with 1.7 ug T4 or 0. 6 To examine further the specificity of T4 and T3 inhibition of TSH-induced rat thyroid ODC, the effects of a variety of iodotyrosines, iodothyronines, and related compounds were studied. The half-maxinmal inhibitory doses of these compounds (obtained, in the first five instances listed, from sigmoid inhibitory doseresponse curves) are listed in Table II .
Of the compounds tested, only triiodothyroacetic acid, D-T4, and diiodothyronine exhibit any significant inhibitory activity.
To determine whether an increase in the dose of exogenous TSH could overcome the inhibitory effect of thyroid hormone on (stimulated) thyroid ODC activity, graded doses of TSH ranging from 1 to 8 U were given to rats pretreated with 0.5 gg T3. As shown in Fig. 3 , the inhibitory effect of T3 is maintained despite increasing doses of exogenous TSH.
The time-course of T4 and T3 inhibition of TSH-induced ODC activity is depicted in Fig. 4 To determine whether an intrathyroidal inhibitor of thyroid ODC is synthesized or activated as a result of thyroid hormone pretreatment, the 20,000 g supernatant fractions prepared fronm glands obtained from T. onlyand TSH only-treated rats were combined and tested for ODC activity. In addition, 0.02 jug T. was added Although the maximal stimulatory effect on both thyroid ODC activity and "I1J release is observed with the same dose of TSH (10 mU), significant augmentation of mouse thyroid hormone release is observed with doses of TSH (e.g., 1 mU, Fig. 5 ) that do not influence ODC activity in the gland.
The time-course of TSH-induced ODC activation and 13.I release after the i.p. administration of 10 mU TSH is depicted in Fig. 6 (Table VII) . Under these conditions, however, pretreatment with larger doses of T4 or T3 (10 Ag) significantly reduces TSH stimulation of thyroid ODC activity.
In contrast to the lack of inhibitory effect of shortterm low-dose thyroid hormone pretreatment, more prolonged (i.e., 24 days) pretreatment with as little as 0.25 Ag daily doses of T4 or T3 results in significant inhibition of TSH-induced mouse thyroid ODC activity (Fig. 7) . In contrast to our findings in the rat (vide supra), Nal pretreatment of the LID mouse also markedly blunts TSH-induced ODC activation. Although larger doses of thyroid hormone or iodide are required than those necessary for ODC inhibition, 21-day thyroid hormone or Nal pretreatment of LID mice inhibits TSH-induced thyroid "31I release (Fig. 8) .
As can be seen from the data depicted in Fig. 9 , the RD mouse pretreated with Nal responds exactly as does the rat, i.e. there is no effect on TSH-induced FIGURE 8 Inhibitory effect of exogenous thyroid hormone or sodium iodide on TSH-stimulated thyroid hormone release in the LID mouse. The mice were pretreated with varying amounts of T4, Ts, or NaI for 3 consecutive days. 4 uCi "3'I had been given i.p. on the 1st day 1 h before the first s.c. injection of T4, Ts, or NaI. On the 4th day, the animals were bled at 0 h, then given 0.5 mU TSH i.p. and bled again 3 h later. The animals pretreated with NaI were also given 0.25 ug T8 s.c. daily to suppress endogenous TSH before exogenous TSH administration.
with 1-day pretreatment only are shown here. If more than 24 h separate the TSH "pretreatment" and the "test" dose of TSH, no inhibition of thyroid ODC activation is observed (data not shown). As was also the case in the rat, no residual "pretreatment" TSH effect on thyroid ODC or serum T4 levels was observed at the time the second or "test" dose of TSH was administered. Although less marked than the reduction in ODC activation, TSH pretreatment does result in FIGURE 9 Effect of exogenous thyroid hormone or sodium iodide pretreatment on TSH-stimulated thyroid ODC activity in the RD mouse. The mice were pretreated with varying amounts of T4, T3, or NaI for 3 consecutive days.
On the 4th day, the animals were killed 4 h after i.p. administration of 10 mU TSH. Each point represents the mean+'SE of three experiments (15 animals per experimental group). * TSH was given i.p. at 11 a.m. on day 1; on day 2, TSH or saline was given i.p. at 7 a.m., 4 h before orbital sinus puncture for serum T4 sampling and sacrifice. $ Each value is the mean±SE of triplicate determinations (six animals per experimental group). § Significantly (P < 0.05 to P < 0.01) less than (day 2, TSH only-treated) group 1.
a lesser (albeit statistically [P < 0.05] significant) rise in serum T4 levels in response to the "test" (day 4) dose of 20 mU TSH (group 3) compared to that observed in nonpretreated animals (group 1).
CYCLIC AMP FORMATION
When LID mice are pretreated with varying amounts of T4 or T3 for 21 days as described in Methods, TSHinduced in vitro stimulation of thyroid cyclic AMP formation is inhibited in a concentration-related manner (Table IX) .
Although qualitatively similar findings with T3 and T4 pretreatment are observed in RD mice, as in the case for ODC activity, Nal pretreatment inhibits TSHinduced thyroid cyclic AMP formation in LID mice only (data not shown here).
As can be seen from Table X, in vitro preincubation of mouse thyroid glands for 3 h with as little as 1 tsg/ml T. markedly inhibited cyclic AMP accumulation induced by a subsequent 30-min incubation with 5 mU TSH. (Addition of the 0.025 N NaOH diluent only to the preincubation was without effect.) Although similar preincubation with NaI at a concentration of 50 AtM (6.3 .g/ml) also effected a more modest reduction in TSH-induced cyclic AMP accumulation, addition of 2 mM methimazole to the preincubation medium abolished the inhibitory iodide effect. The inhibitory effect of T4 could not be reproduced by up to 20 Asg/ml triiodothyroacetic acid or D-T4 nor was it affected by addition of methimazole to the preincubation medium (data not shown here).
DISCUSSION
The thesis that the thyroid gland might be ". . . directly inhibited by its own hormone . ." was first advanced by Galli-Mainini in 1941 (9) . He reported that the in
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S. Yu, Y. Friedman, R. Richman, and G. Burke vitro stimulatory effect of TSH on oxygen consumption by guinea pig thyroid slices was inhibited by the addition of thyroid hormone to the incubation medium. In 1944, Cortell and Rawson (10) reported that the administration of T4 to the immature female guinea pig depresses thyroidal response to exogenous TSH as determined by the mean cell height of the thyroid epithelium. These authors also noted that the administration of T4 to hypophysectomized male rats depressed thyroidal response to exogenous TSH as determined both by mean thyroid epithelial cell height as well as by thyroidal radioiodine uptake (10) . The possible impli- (2) . The results of the present study confirm and extend these observations. Thus, a number of exogenous TSH effects on murine thyroid, including stimulation of cyclic AMP formation and hormone release, are inhibited by prior administration of thyroid hormone to the experimental animals. The inhibitory effect is concentrationrelated and achieved at a dose (and resultant circulating concentration) of T4 and/or T3 comparable to that required for inhibition of goitrogenesis in the rat (11) and/or that resulting in inhibition of thyrotropin-releasing hormone-TSH release response in the mouse (12) . The inhibitory effect in the rat appears to be reasonably specific for iodothyronines. In contrast, Nal is also inhibitory in the LID but not in the RD mouse. We believe the inhibitory effect of Nal in the LID mouse merely reflects avid uptake of iodide by the iodine-depleted thyroid gland and its rapid incorporation into intrathyroidal thyroid hormone ( 2) that a reduction in the colloid droplet response was also observed in thyroid glands of mice pretreated with large doses of T3 in vivo and incubated with TSH or LATS in vitro. Additionally, an inhibitory effect of T4 and/or T3 on the in vitro stimulation of mouse thyroid cyclic AMP formation by TSH is demonstrable when the extirpated mouse thyroid gland is preincubated with thyroid hormone (Table X) .
Since exposure of the thyroid gland to increased circulating thyroid hormone levels blunts the stimulatory effect of exogenous TSH, one would anticipate that "pretreatment" of the experimental animal with TSH and the consequent increase in circulating T4 and T3 levels should result in decreased thyroidal response to further TSH administration. Such was found to be the case in both rat and mouse when TSH effects on ODC activation and thyroid hormone release were tested under these conditions. These observations, as well as the inhibitory effect of T4/T3 pretreatment on TSHinduced thyroid ODC activity in hypophysectomized rats and the demonstration of an in vitro inhibitory effect of thyroid hormone on TSH-stimulated mouse thyroid cyclic AMP formation, do not support the recent suggestion of Gafni et al. (15) that reduced thyroidal response to TSH following pretreatment of mice with T3 is a consequence of (endogenous) TSH "withdrawal."
Although the inhibitory effect of T4 and/or T3 pretreatment on TSH-induced ODC activation persists for up to 4 days, the t2 of exchangeable tissue T3 in the rat varies between only 4 and 6 h (16). In this regard, the inhibition by circulating thyroid hormones of thyroidal response to TSH parallels a variety of tissue effects of injected T3 in thyroidectomized rats wherein all of the observed effects of the hormone appear to decline with similar t2's in the order of 4-6 days (17) (18) (19) . Thus, our findings merely represent yet another instance where the tissue effect of the hormone appears to persist long after all of the administered hormone has disappeared from the circulation.
The precise relationship of ODC activation in thyroid to hormonogenesis or hormone secretion is uncertain. We (5), and others (20) have recently shown that the activity of the latter enzyme, which catalyzes the initial step in polyamine synthesis from ornithine, is regulated by endogenous circulating TSH. To the extent that ODC activity may serve as a biological marker for the growth-promoting effects of TSH, the inhibitory effect of thyroid hormone on TSH-induced ODC activation suggests that both hormone secretion and gland growth can be directly inhibited by circulating thyroid hormones. Clearly, the precise locus and nature of this inhibition remains to be defined. While there is currently some disagreement as to wvhether such inhibition occurs before (15) or beyond (21) cyclic AMP formation, the inhibition by thyroid hormone of TSH-induced cyclic AMP formation 2 in the gland as reported here may well be of pivotal importance. (Since thyroid hormones have been shown to inhibit rather than augment thyroid cyclic AMP phosphodiesterase activity [23, 24] , the inhibition of TSH-induced cyclic AMP formation cannot be attributed to thyroid hormone-induced enhancement of the activity of the degradative enzyme.)
In this regard, the recent observation of Takasu et al. (25) suggest that the findings reported here may be relevant to the pathogenesis of Graves' hyperthyroidism in man. These workers reported that addition of T4 or T-in vitro decreased TSH stimulation of adenylate cyclase and cyclic AMP formation in plasma membrane fractions and slices prepared from thyroid glands surgi-2 Although we have been unable to demonstrate a dibutyryl cyclic AMP effect on rat thyroid ODC (5), Zussman and Burrow (22) recently reported that dibutyryl cyclic AMP and aminophylline caused a 12-fold increase in rat thyroid ODC activity 5 h after administration.
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S. Yu, Y. Friedman, R. Richman, and G. Burke cally removed from euthyroid subjects. Since thyroid tissue from hyperthyroid patients was less susceptible to T4-and T3-induced suppression of TSH-augmented adenylate cyclase activation and cyclic AMP formation, Takasu et al. suggested that thyroid hormones play an important role in the control of human thyroid function through depression of the thyroidal adenylate cyclasecyclic AMP system activated by TSH (25) . Thus, from the results of studies of other workers as well as our own, it appears reasonable to conclude that thyroidal responsivity to TSH is altered under the influence of circulating thyroid hormones and, further, to suggest the existence of a thyroid-hormone-mediated "short-loop" negative feedback important in the regulation of thyroid function.
